✦ LIBER ✦

Phase II study of a 72-h concurrent continuous infusion of cisplatin and etoposide in advanced non-small-cell lung cancer

✍ Scribed by Hiroshi Saito; Kaoru Shimokata; Masashi Yamamoto; Hideo Saka; Shuzo Sakai; Hidehiko Saito

Publisher: Springer
Year: 1993
Tongue: English
Weight: 331 KB
Volume: 32
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf00685616

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concurrent radiation and weekly cisplati

Concurrent radiation and weekly cisplatin for non-small-cell lung cancer — a phase I/II study

✍ Raymond P. Abratt; Paul A. Willcox; D. G. Mame Salton 📂 Article 📅 1992 🏛 Springer 🌐 English ⚖ 299 KB

Continuous-infusion cisplatin, 5-fluorou

Continuous-infusion cisplatin, 5-fluorouracil, and bolus methotrexate in the treatment of advanced non-small cell lung cancer

✍ Thomas J. Lynch Jr.; John R. Clark; Leslie A. Kalish; Barbara G. Fallon; Anthony 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 531 KB

Cisplatin, etoposide, and ifosfamide in

Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm

✍ Adriano Paccagnella; Adolfo Favaretto; Alba Brandes; Cristina Ghiotto; Driano Fo 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 434 KB 👁 2 views

Carboplatin and vinblastine in advanced

Carboplatin and vinblastine in advanced non-small-cell lung cancer: a phase II study

✍ D. Doll; M. Goutsou; S. Graziano; J. Ellerton; J. Bitran; C. Modeas; J. Herndon; 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 426 KB

Phase II trial of etoposide and cisplati

Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: A cancer and leukemia group B study

✍ Graziano, Stephen L. ;Lee, Kewchang ;Propert, Kathleen J. ;Tinsley, Roger ;Hayes 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 466 KB 👁 1 views

## Abstract A phase II trial of etoposide and cisplatin for patients with previously treated small cell lung cancer was carried out by CALGB from June 1983 to May 1984. Thirty‐five evaluable patients who had failed one prior chemotherapy regimen were treated with etoposide 80 mg/m^2^ and cisplatin

Phase I study of mitonafide in 120 hour

Phase I study of mitonafide in 120 hour continuous infusion in non-small cell lung cancer

✍ Rafael Rosell; Joan Carles; Alberto Abad; Nuria Ribelles; Agustin Barnadas; Ana 📂 Article 📅 1992 🏛 Springer US 🌐 English ⚖ 286 KB